Spyre Therapeutics, Inc. logo

Spyre Therapeutics, Inc. (SYRE)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
100. 23
+6.11
+6.4917%
$
5.9B Market Cap
- P/E Ratio
- Div Yield
1.09M Volume
- Eps
$ 94.12
Previous Close
Add Transaction
Day Range
92.37 101.36
Year Range
14.51 105.09
Want to track SYRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Spyre Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
18,360 $422,829.51 $1.84M $1.42M 335.22%
BGI
B Group Inc. B Group Inc.
100,000 $1.97M $10.02M $8.05M 408.37%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
4,803 $202,553.91 $481,404.69 $278,850.78 137.67%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,743 $46,746.62 $174,700.89 $127,954.27 273.72%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
170,381 $4.53M $17.08M $12.54M 276.58%